Merger • Medical Products

Globus Medical Acquires NuVasive

On April 27, 2023, Globus Medical acquired medical products company NuVasive

Acquisition Context
  • This is Globus Medical’s 6th transaction in the Medical Products sector.
  • This is Globus Medical’s 8th transaction in the United States.
  • This is Globus Medical’s 2nd transaction in California.

Explore All 68 Merger Medical Products Deals - Search the Database Free


M&A Deal Summary

Date April 27, 2023
Target NuVasive
Sector Medical Products
Buyer(s) Globus Medical
Deal Type Merger

Target Company

NuVasive

San Diego, California, United States
Entrance to NuVasive's corporate headquarters in San Diego, California.
Entrance to NuVasive's corporate headquarters in San Diego, California.
NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. NuVasive was formed in 1997 and is based in San Diego, California.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Globus Medical

Audubon, Pennsylvania, United States

Category Company
Founded 2003
Sector Medical Products
Employees5,300
Revenue 2.5B USD (2024)
DESCRIPTION

Globus Medical is a musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. Globus Medical was founded in 2003 and is based in Audubon, Pennsylvania.


Deal Context for Buyer #
Overall 9 of 10
Sector: Medical Products 6 of 7
Type: Merger 1 of 1
State: California 2 of 3
Country: United States 8 of 9
Year: 2023 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-21 Synoste Oy

Espoo, Finland

Synoste develops a high-tech implant for a minimally invasive treatment of leg length discrepancy, that can lead to chronic back pain and osteoarthritis in the long term. The bone of the shorter leg is lengthened in a gentle way over a period of several months. The Evonik material used in the implant is a high-performance polymer called polyetheretherketone, or PEEK. The material is biocompatible - not harmful or toxic to living tissue and has excellent mechanical properties. For the patient the implant represents easier treatment with less pain and lower risk compared to previously established methods. Synoste was formed in 2012 and is based in Espoo, Finland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2025-02-06 Nevro

Redwood City, California, United States

Nevro is a medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro was founded in 2006 and is based in Redwood City, California.

Buy $250M